Study of allergic disorders using mouse model
Arerugi. 2024;73(1):1-5. doi: 10.15036/arerugi.73.1.NO ABSTRACTPMID:38403694 | DOI:10.15036/arerugi.73.1 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Satoshi Nunomura Source Type: research

Definition and diagnosis of refractory/severe asthma
Arerugi. 2024;73(1):11-13. doi: 10.15036/arerugi.73.11.NO ABSTRACTPMID:38403695 | DOI:10.15036/arerugi.73.11 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Yasuhiro Gon Source Type: research

The innate immune network and therapeutic approaches in asthma
Arerugi. 2024;73(1):14-20. doi: 10.15036/arerugi.73.14.NO ABSTRACTPMID:38403696 | DOI:10.15036/arerugi.73.14 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Rie Baba Hiroki Kabata Koichi Fukunaga Source Type: research

Prospects for the commitment of genetic big data to allergy medicine
Arerugi. 2024;73(1):21-25. doi: 10.15036/arerugi.73.21.NO ABSTRACTPMID:38403697 | DOI:10.15036/arerugi.73.21 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Hideyasu Yamada Source Type: research

Advances in diagnosis and treatment in eosinophilic granulomatosis with polyangiitis (egpa)
Arerugi. 2024;73(1):26-33. doi: 10.15036/arerugi.73.26.NO ABSTRACTPMID:38403698 | DOI:10.15036/arerugi.73.26 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Masami Taniguchi Yosuke Kamide Yuto Nakamura Kentaro Watai Yuma Fukutomi Kiyoshi Sekiya Source Type: research

A case of clinically amyopathic dermamyositis with interstitial lung disease showing two deteriorations in 4 years
We report the case of a 45-year-old man who was diagnosed with clinically amyopathic dermamyositis (CADM) and interstitial lung disease (ILD) after presenting with skin lesions typical of CADM and testing positive for anti-Melanoma Diferentiation-Associated gene 5 (anti-MDA5) anti-bodies. He was treated with a regimen including steroid pulse therapy, intravenous cyclophosphamide (IVCY), and calcineurin Inhibitor drug, which initially improved his ILD. However, three months post-treatment, the first deterioration of his conditions occurred, necessitating further administration of steroid pulse therapy and IVCY. After eight ...
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Takashi Yamane Tomoyuki Urata Source Type: research

The efficacy of bronchial thermoplasty in long-term maintenance of adult patients with moderate to severe asthma
CONCLUSION: From a risk-benefit perspective, there is insufficient evidence to support a recommendation of BT in adult patients with moderate to severe asthma.PMID:38403700 | DOI:10.15036/arerugi.73.40 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Takahiro Matsuyama Jun Tanaka Kazuya Tone Kaoruko Shimizu Takako Nakano Koichiro Takahashi Source Type: research

(no title)
Arerugi. 2024;73(1):52-53. doi: 10.15036/arerugi.73.52.NO ABSTRACTPMID:38403701 | DOI:10.15036/arerugi.73.52 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Source Type: research

(no title)
Arerugi. 2024;73(1):54-55. doi: 10.15036/arerugi.73.54.NO ABSTRACTPMID:38403702 | DOI:10.15036/arerugi.73.54 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Source Type: research

(no title)
Arerugi. 2024;73(1):56-58. doi: 10.15036/arerugi.73.56.NO ABSTRACTPMID:38403703 | DOI:10.15036/arerugi.73.56 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Source Type: research

(no title)
Arerugi. 2024;73(1):59-62. doi: 10.15036/arerugi.73.59.NO ABSTRACTPMID:38403704 | DOI:10.15036/arerugi.73.59 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Source Type: research

Mast cells, basophils and allergy
Arerugi. 2024;73(1):6-9. doi: 10.15036/arerugi.73.6.NO ABSTRACTPMID:38403705 | DOI:10.15036/arerugi.73.6 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Yoshimichi Okayama Source Type: research

Study of allergic disorders using mouse model
Arerugi. 2024;73(1):1-5. doi: 10.15036/arerugi.73.1.NO ABSTRACTPMID:38403694 | DOI:10.15036/arerugi.73.1 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Satoshi Nunomura Source Type: research

Definition and diagnosis of refractory/severe asthma
Arerugi. 2024;73(1):11-13. doi: 10.15036/arerugi.73.11.NO ABSTRACTPMID:38403695 | DOI:10.15036/arerugi.73.11 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Yasuhiro Gon Source Type: research

The innate immune network and therapeutic approaches in asthma
Arerugi. 2024;73(1):14-20. doi: 10.15036/arerugi.73.14.NO ABSTRACTPMID:38403696 | DOI:10.15036/arerugi.73.14 (Source: Arerugi)
Source: Arerugi - February 25, 2024 Category: Allergy & Immunology Authors: Rie Baba Hiroki Kabata Koichi Fukunaga Source Type: research